Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Akari Therapeutics stock
Learn how to easily invest in Akari Therapeutics stock.
Akari Therapeutics PLC is a biotechnology business based in the US. Akari Therapeutics shares (AKTX) are listed on the NASDAQ and all prices are listed in US Dollars. Akari Therapeutics employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Akari Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Akari Therapeutics stock price (NASDAQ: AKTX)Use our graph to track the performance of AKTX stocks over time.
Akari Therapeutics shares at a glance
|Latest market close||$0.56|
|52-week range||$0.54 - $1.83|
|50-day moving average||$1.10|
|200-day moving average||$1.21|
|Wall St. target price||$5.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.41|
Buy Akari Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akari Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Akari Therapeutics price performance over time
|1 week (2022-09-21)||-9.53%|
|1 month (2022-08-26)||-53.02%|
|3 months (2022-06-28)||-41.46%|
|6 months (2022-03-28)||-54.91%|
|1 year (2021-09-28)||-66.92%|
|2 years (2020-09-28)||-67.11%|
|3 years (2019-09-27)||1.69|
|5 years (2017-09-28)||6.31|
Akari Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-77.44%|
|Return on equity TTM||-187.62%|
|Market capitalisation||$35.6 million|
TTM: trailing 12 months
Akari Therapeutics share dividends
We're not expecting Akari Therapeutics to pay a dividend over the next 12 months.
Have Akari Therapeutics's shares ever split?
Akari Therapeutics's shares were split on a 1:10 basis on 16 September 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akari Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Akari Therapeutics shares which in turn could have impacted Akari Therapeutics's share price.
Akari Therapeutics share price volatility
Over the last 12 months, Akari Therapeutics's shares have ranged in value from as little as $0.54 up to $1.829. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akari Therapeutics's is 1.2369. This would suggest that Akari Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Akari Therapeutics overview
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom. .
Akari Therapeutics in the news
Akari Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Pipeline Progress
Akari Therapeutics to Participate in the Cantor Oncology & HemOnc Conference
Akari Therapeutics Announces $12.75 Million Registered Direct Offering
Frequently asked questionsWhat percentage of Akari Therapeutics is owned by insiders or institutions?
Currently 3.899% of Akari Therapeutics shares are held by insiders and 2.392% by institutions. How many people work for Akari Therapeutics?
Latest data suggests 9 work at Akari Therapeutics. When does the fiscal year end for Akari Therapeutics?
Akari Therapeutics's fiscal year ends in December. Where is Akari Therapeutics based?
Akari Therapeutics's address is: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT What is Akari Therapeutics's ISIN number?
Akari Therapeutics's international securities identification number is: US00972G1085 What is Akari Therapeutics's CUSIP number?
Akari Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00972G108
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert